Karin Walker

Director/Miembro de la Junta en CYCLACEL PHARMACEUTICALS, INC. .

Fortuna: 11 106 $ al 31/05/2024

60 años

Health Technology

Process Industries

Finance

Cargos activos de Karin Walker

Empresas	Cargo	Inicio	Fin
PROTHENA CORPORATION PLC	Comptroller/Controller/Auditor	20/05/2013	-
CYCLACEL PHARMACEUTICALS, INC.	Director/Miembro de la Junta	09/11/2020	-
CYCLACEL PHARMACEUTICALS, INC.	Independent Dir/Board Member	09/11/2020	-

Empresas	Cargo	Inicio	Fin
VINCERX PHARMA, INC.	Director/Miembro de la Junta	05/03/2020	23/12/2020
VINCERX PHARMA, INC.	Independent Dir/Board Member	05/03/2020	23/12/2020
AFFYMAX, INC.	Comptroller/Controller/Auditor	02/10/2012	01/05/2013
AMYRIS, INC.	Comptroller/Controller/Auditor	01/01/2009	01/09/2012
CV Therapeutics, Inc. CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases	Comptroller/Controller/Auditor	01/06/2006	01/08/2009
Ernst & Young US LLP Ernst & Young US LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young US LLP was engaged in providing accounting services. The company was headquartered in Pittsburgh, PA.	Corporate Officer/Principal	-	-

California Polytechnic State University (San Luis Obispo)

Undergraduate Degree

Internacional

Estados Unidos	8
Irlanda	2

Operativa

Comptroller/Controller/Auditor	4
Director/Board Member	2
Independent Dir/Board Member	2

Sectorial

Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Empresas cotizadas	4
AFFYMAX, INC.	Health Technology
PROTHENA CORPORATION PLC	Health Technology
AMYRIS, INC.	Process Industries
CYCLACEL PHARMACEUTICALS, INC.	Health Technology

Empresas privadas	3
CV Therapeutics, Inc. CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases	Health Technology
LifeSci Acquisition Corp. LifeSci Acquisition Corp. Financial ConglomeratesFinance LifeSci Acquisition Corp. operates as a blank check company. It was formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities. The company was founded on December 19, 2018 and is headquartered in New York, NY.	Finance
Ernst & Young US LLP Ernst & Young US LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young US LLP was engaged in providing accounting services. The company was headquartered in Pittsburgh, PA.	Commercial Services